| OBI PHARMA OBI PHARMA, INC.
86014025 18 Jul 2013 | on 02 Apr 2022
| Antibiotic preparations; Antibiotics; Anti-cancer preparations; Anti-i... Class 005 Class 005 Pharmaceutical Products "PHARMA" | | | GLOBOVAX OBI PHARMA, INC.
87926196 17 May 2018 | on 26 Mar 2019
| Pharmaceutical preparations, namely, vaccine for anti-cancer; chemical... Class 005 Class 005 Pharmaceutical Products The color(s) pink and black is/are claimed as a feature of the mark. | | | GLYCODX OBI PHARMA, INC.
86790734 16 Oct 2015 | on 16 Oct 2018
| amino acids for medical purposes; biological preparations for the trea... Class 005 Class 005 Pharmaceutical Products amino acids for medical purposes; biological preparations for the treatment of immune system related diseases, cancer and infectious diseases for medical purposes; blood for medical purposes; blood plasma; capsules sold empty for pharmaceuticals; chemical reagents for medical purposes; chemical preparations for medical purposes, namely, for the diagnosis, monitoring, treatment and prevention of immune system related diseases, cancer and infectious diseases; chemical preparations for pharmaceutical purposes, namely, for the diagnosis, monitoring, treatment and prevention of immune system related diseases, cancer and infectious diseases; chemico-pharmaceutical preparations for the treatment of immune system related diseases, cancer and infectious diseases for medical purposes; detergents for medical purposes; diagnostic preparations for medical purposes; diagnostic biomarker reagents for medical purposes; drugs for medical purpose, namely, pharmaceutical preparations for the treatment of immune system related diseases, cancer and infectious diseases; pharmaceutical preparations for treatment of immune system related diseases, cancer and infectious diseases; reagent paper for medical purposes; medicated serums for treatment of immune system related diseases, cancer and infectious diseases; sugar for medical purposes; vaccines; Anti-cancer preparations; Biological preparations for the treatment of cancer; Diagnostic agents, preparations and substances for medical purposes; Diagnostic kits consisting primarily of monoclonal antibodies, buffers and reagents for use in disease testing; Diagnostic preparations for medical or veterinary purposes; Diagnostic preparations for medical purposes for detecting the presence of malignant, inflammatory and autoimmune disorders and conditions and tissue trauma in humans; Diagnostic radiopharmaceutical preparations; Diagnostic reagents for medical use; Diagnostic reagents and contrast media for medical use; Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; In-vivo diagnostic agent used for detection and monitoring of angiogenesis and antiangiogenic therapy; Medical diagnostic reagents; Medical diagnostic reagents and assays for testing body fluids; Medical diagnostic reagents for the analysis of body fluids; Medicinal preparations for the treatment of infectious diseases and for using in oncology; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical products for the prevention and treatment of cancer; Reagents for medical use; Vaccine adjuvants; Vaccine preparations; Vaccine stabilizers | | | GLOBOVAX OBI PHARMA, INC.
86879881 19 Jan 2016 | on 12 Jun 2018 | adjuvants for medical purposes; amino acids for medical purposes; amin... Class 005 Class 005 Pharmaceutical Products adjuvants for medical purposes; amino acids for medical purposes; amino acids for veterinary purposes; soap-bark tree, quillaja, quillais and Quillaja saponaria Molina barks for pharmaceutical purposes; biological preparations for medical purposes, namely, for the diagnosis, monitoring, treatment and prevention of immune system related diseases, cancer and infectious diseases; biological preparations for veterinary purposes, namely, for the diagnosis, monitoring, treatment and prevention of immune system related diseases, cancer and infectious diseases; drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; chemical reagents for medical or veterinary purposes; chemical preparations for medical purposes, namely, for the diagnosis, monitoring, treatment and prevention of immune system related diseases, cancer and infectious diseases; chemical preparations for pharmaceutical purposes, namely, for the diagnosis, monitoring, treatment and prevention of immune system related diseases, cancer and infectious diseases; chemical preparations for veterinary purposes, namely, for the diagnosis, monitoring, treatment and prevention of immune system related diseases, cancer and infectious diseases; chemico-pharmaceutical preparations for the diagnosis, monitoring, treatment and prevention of immune system related diseases, cancer and infectious diseases; drugs for medical purposes, namely, for the diagnosis, monitoring, treatment and prevention of immune system related diseases, cancer and infectious diseases; glucose for medical purposes; milk sugar for pharmaceutical purposes; lactose for pharmaceutical purposes; medicinal roots; medicinal herbs; medicinal oils; medicinal infusions for the diagnosis, monitoring, treatment and prevention of immune system related diseases, cancer and infectious diseases; medicines for human purposes, namely, for the diagnosis, monitoring, treatment and prevention of immune system related diseases, cancer and infectious diseases; medicines for veterinary purposes, namely, for the diagnosis, monitoring, treatment and prevention of immune system related diseases, cancer and infectious diseases; pharmaceutical preparations for the diagnosis, monitoring, treatment and prevention of immune system related diseases, cancer and infectious diseases; phosphates for pharmaceutical purposes, namely, for the diagnosis, monitoring, treatment and prevention of immune system related diseases, cancer and infectious diseases; potassium salts for medical purposes; reagent paper for medical or veterinary purposes; mineral salts for medical purposes; sodium salts for medical purposes; sugar for medical purposes; vaccines; veterinary preparations for the diagnosis, monitoring, treatment and prevention of immune system related diseases, cancer and infectious diseases; yeast for pharmaceutical purposes; acetates for pharmaceutical purposes, namely, for the diagnosis, monitoring, treatment and prevention of immune system related diseases, cancer and infectious diseases; acids for pharmaceutical purposes, namely, for the diagnosis, monitoring, treatment and prevention of immune system related diseases, cancer and infectious diseases; alginates for pharmaceutical purposes; blood for medical purposes; blood plasma; diagnostic preparations for medical purposes; diagnostic biomarker reagents for medical purposes; diastase for medical purposes; enzyme preparations for medical purposes; enzymes for medical purposes; ferments for pharmaceutical purposes; medicated pastilles for pharmaceutical purposes; medicated lozenges for pharmaceutical purposes; flour for pharmaceutical purposes; meal for pharmaceutical purposes; hormones for medical purposes; milk ferments for pharmaceutical purposes; cultures of microorganisms for medical and veterinary use; preparations of microorganisms for medical and veterinary use, namely, nutritive substances for microorganisms for medical and veterinary use; serotherapeutic medicines for the diagnosis, monitoring, treatment and prevention of immune system related diseases, cancer and infectious diseases; medicated serums for the diagnosis, monitoring, treatment and prevention of immune system related diseases, cancer and infectious diseases; stem cells for medical purposes; anti-cancer preparations; adjuvants for use with vaccines; biological preparations for the treatment of cancer. drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; ferments for medical or veterinary use; human vaccine preparations; medicinal preparations for the treatment of infectious diseases and for use in oncology; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; pharmaceutical products for the prevention and treatment of cancer; pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; reagents for medical use; vaccine adjuvants; vaccine preparations; vaccine stabilizers | |